Dariusz Boruczkowski, Dominika GÅadysz, Mariusz Grudniak, Karol Kosterna and Katarzyna Pawelec
It has been postulated that mesenchymal stem cells could play a role in treatment of patients with amyotrophic lateral sclerosis. Variety of mechanism behind MSC action has been proposed including immunomodulation and delivery of trophic factors. The scientific rationale in preclinical studies is being proved along with first clinical uses. Recent advances in stem cell research rises new hope for patients with ALS.